CAD 0.03
(-16.67%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | - CAD | 100.0% |
2022 | -24.71 CAD | -53.93% |
2021 | -16.06 CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | - CAD | 0.0% |
2024 Q3 | - CAD | 0.0% |
2024 Q1 | - CAD | 0.0% |
2023 FY | - CAD | 100.0% |
2023 Q4 | - CAD | 0.0% |
2023 Q3 | - CAD | 0.0% |
2023 Q2 | - CAD | 0.0% |
2023 Q1 | - CAD | 100.0% |
2022 FY | -24.71 CAD | -53.93% |
2022 Q3 | -7883.00 CAD | 0.0% |
2022 Q2 | - CAD | 100.0% |
2022 Q4 | -11.00 CAD | 99.86% |
2022 Q1 | -16.82 Thousand CAD | -4.76% |
2021 Q1 | - CAD | 0.0% |
2021 Q4 | -16.05 Thousand CAD | 0.0% |
2021 Q3 | - CAD | 0.0% |
2021 Q2 | - CAD | 0.0% |
2021 FY | -16.06 CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
AI/ML Innovations Inc. | 294.86 Thousand CAD | 100.0% |
Pangenomic Health Inc. | -681.43 Thousand CAD | 100.0% |
nDatalyze Corp. | 65.2 Thousand CAD | 100.0% |
Treatment.Com International Inc. | - CAD | NaN% |
Unidoc Health Corp. | -68.26 Thousand CAD | 100.0% |